by Stren & Blan Partners | Sep 18, 2025 | Health and Pharmaceutical, Insight
Public-Private Partnerships (PPPs) are becoming an increasingly important mechanism for financing, building, and operating healthcare infrastructure and services in Nigeria. With government budgets stretched and demand for quality healthcare rising, PPPs offer a way...
by Stren & Blan Partners | Sep 4, 2025 | Health and Pharmaceutical, Insight
The advent of telemedicine has redefined healthcare delivery globally, and Nigeria is no exception. Telemedicine emerged as a result of technological advancements and its increasing integration into daily life. It involves the use of telecommunications and digital...
by Stren & Blan Partners | Jul 21, 2025 | Health and Pharmaceutical, Insight
The second quarter of 2025 marked a dynamic phase in Nigeria’s health sector, defined by reforms in pharmaceutical manufacturing, international collaboration, and stringent regulatory enforcement. The Federal Government announced a two-year exemption on import duty...
by Stren & Blan Partners | May 15, 2025 | Health and Pharmaceutical, Insight
Artificial intelligence (AI) is reshaping the global healthcare landscape, enhancing efficiency, diagnostics, and patient outcomes. With Nigeria witnessing a surge in AI-driven healthcare innovations, businesses must navigate an evolving regulatory framework to...
by Stren & Blan Partners | Jan 30, 2025 | Health and Pharmaceutical, Insight
In 2024, Nigeria’s health and pharmaceutical sector witnessed significant transformations, driven by key market developments and efforts to strengthen the domestic pharmaceutical industry. One of the most impactful changes was the introduction of a new framework...
